// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

I felt like I’d been given a new lease of life: Exploring the information needs and experiences of people with rheumatoid arthritis receiving bridging glucocorticoids when starting methotrexate

Sarah J Logan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Glucocorticoid

A review of published data on reported staffing ratios for rheumatology specialist physiotherapists in rheumatology departments

William J Gregory - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Initial Impacts of the UK-Wide Rheumatology Physiotherapy Capabilities Framework

William J Gregory - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Developing multidisciplinary models of care in rheumatology at University College London Hospital: 18 months of learning from conception to delivery and beyond

Fern Higgs - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A systematic review of audit and feedback tools to reduce opioid prescribing for chronic non-cancer pain

Joshua Feldman - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

Epimorph

Implementation of a disease modifying anti-rheumatic drug blood monitoring software: 8 years of experience in a single centre

Anindita Paul - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

COVID-19 in male elite Irish-based athletes at a national sports institute

Michael McLarnon - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

C-reactive protein rise in rheumatology patients following COVID-19 vaccination

Sung-Hee Kim - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory Arthritis

N/A

A systematic review of new rheumatic immune-mediated inflammatory diseases (R-IMID) following SARS-CoV-2 vaccinations

Arvind Nune - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Lupus

N/A

The effects of a pain management programme for patients with an inflammatory arthritis

Kelley Corcoran - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Testing a new prototype osteoporosis shared decision-making intervention in UK Fracture Liaison Services: patient and clinician perspectives of ‘iFraP’

Laurna Bullock - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

Do proformas used in Fracture Liaison Service appointments reflect national osteoporosis clinical standards? A content analysis

Sittana Abdelmagid - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

N/A

A rare hereditary haemochromatosis type three (3) related arthritis

Hafiz Muhammad Umair - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Scoping review for the application of centre of pressure for patient or intervention assessment in rheumatoid conditions

Fraser S Goodwin - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Using social network platforms to evaluate patient perceptions of CBD products in the UK, US, and Canada

Safeena Minhas - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Cannabidiol

Four SNPs associated with monocyte/macrophage cell lineage uniquely associated with CRPS-1 in discovery and replication cohorts and suggest predisposition to regional osteopaenia and digit misperception

Nick Shenker - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Other

Fibromyalgia

N/A

A systematic review assessing the comparative harms associated with opioids for musculoskeletal pain

Craig McCarthy - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Antagonism of IL-27 bioactivity

Lara Green - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute Leukemia

N/A

How well is the mental health of rheumatoid arthritis patients assessed in the routine rheumatology clinic?

Hannah Cooney - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Which clinical, ultrasound and OT hand assessments are most useful in predicting hand disability in early rheumatoid arthritis?

Cathryn Harkness - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved